Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oncolytic viruses: a new class of immunotherapy drugs.

Literature DB >> 30907381

Oncolytic viruses: a new class of immunotherapy drugs.

Howard L Kaufman, Frederick J Kohlhapp, Andrew Zloza.

Abstract

This corrects the article DOI: 10.1038/nrd4663.

Year: 2016 PMID： 30907381 DOI： 10.1038/nrd.2016.178

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

1 in total

Review 1. Oncolytic viruses: a new class of immunotherapy drugs.

Authors: Howard L Kaufman; Frederick J Kohlhapp; Andrew Zloza
Journal: Nat Rev Drug Discov Date: 2015-09 Impact factor: 84.694

1 in total

20 in total

Review 1. Cancer immunotherapy: a promising dawn in cancer research.

Authors: Banashree Bondhopadhyay; Sandeep Sisodiya; Atul Chikara; Asiya Khan; Pranay Tanwar; Dil Afroze; Neha Singh; Usha Agrawal; Ravi Mehrotra; Showket Hussain
Journal: Am J Blood Res Date: 2020-12-15

Review 2. Novel classes of immunotherapy for breast cancer.

Authors: Alberto Hernando-Calvo; David W Cescon; Philippe L Bedard
Journal: Breast Cancer Res Treat Date: 2021-10-08 Impact factor: 4.872

3. In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.

Authors: Bin Zhang; Yongheng Shu; Shichuan Hu; Zhongbing Qi; Yanwei Chen; Jinhu Ma; Yunmeng Wang; Ping Cheng
Journal: Front Oncol Date: 2022-06-28 Impact factor: 5.738

4. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.

Authors: Edward C Koellhoffer; Chenkai Mao; Veronique Beiss; Lu Wang; Steven N Fiering; Christine E Boone; Nicole F Steinmetz
Journal: Mol Pharm Date: 2022-01-03 Impact factor: 5.364

Review 5. Promises and challenges of adoptive T-cell therapies for solid tumours.

Authors: Matteo Morotti; Ashwag Albukhari; Abdulkhaliq Alsaadi; Mara Artibani; James D Brenton; Stuart M Curbishley; Tao Dong; Michael L Dustin; Zhiyuan Hu; Nicholas McGranahan; Martin L Miller; Laura Santana-Gonzalez; Leonard W Seymour; Tingyan Shi; Peter Van Loo; Christopher Yau; Helen White; Nina Wietek; David N Church; David C Wedge; Ahmed A Ahmed
Journal: Br J Cancer Date: 2021-03-29 Impact factor: 7.640

Oncolytic viruses: a new class of immunotherapy drugs.

Review 1. Oncolytic viruses: a new class of immunotherapy drugs.

Review 1. Cancer immunotherapy: a promising dawn in cancer research.

Review 2. Novel classes of immunotherapy for breast cancer.

3. In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity.

4. Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model.

Review 5. Promises and challenges of adoptive T-cell therapies for solid tumours.

Review 6. Oncolytic viruses for cancer immunotherapy.

Review 7. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.

8. Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers.

Review 9. Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials.

Review 10. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.